CHMP issues positive opinion for Beovu

December 13, 2019
Beovu has received a positive opinion from the Committee for Medicinal Products for Human Use of the European Medicines Agency, Novartis announced in…

LHON patients see ‘dramatic, irreversible’ vision decline without treatment

December 12, 2019
A natural history study shows patients who have Leber’s hereditary optic neuropathy with the ND4 mutation have a dramatic and irreversible…

Eylea prefilled syringe now available

December 12, 2019
The Eylea injection prefilled syringe is now available to order, Regeneron Pharmaceuticals announced. The Eylea (aflibercept) 2 mg, single-dose…

First patient dosed in ProQR retinitis pigmentosa trial

December 12, 2019
ProQR Therapeutics has dosed the first patient in a phase 1/2 trial of QR-1123, its treatment candidate for autosomal dominant retinitis pigmentosa…

In the Journals

Nicotine reduces macular microcirculation

December 11, 2019
A decrease in macular microcirculation was detected after nicotine use, according to a study. Eighteen young, healthy, nonsmoking subjects and 18…

In the Journals

Ocriplasmin effective for resolution of vitreomacular traction

December 10, 2019
A phase 4 multicenter study found nearly half of patients with vitreomacular traction, with or without macular hole, who received an intravitreal…

From OSN Europe

GenSight’s LHON treatment receives French temporary authorization for use

December 10, 2019
A patient at France’s National Eye Hospital of the Quinze-Vingts has been granted temporary authorization for use of Lumevoq, GenSight…

Meeting NewsVideo

VIDEO: ERG can detect retinal ischemia

December 9, 2019
NEPTUNE, N.J. – ERG was shown to detect retinal ischemia before the presence of retinopathy, unveiling retinal function changes that may not be…

Study to focus on microgravity’s effect on microcirculation

December 6, 2019
A research study evaluating the effects microgravity has on the central microcirculation of the bodies of astronauts and jet pilots will begin in…

Foundation Fighting Blindness launches retinitis pigmentosa natural history study

December 5, 2019
A natural history study for people with retinitis pigmentosa caused by mutations in the gene EYS has been launched by the Foundation Fighting…

Benelux countries approve Iluvien for noninfectious posterior uveitis

December 4, 2019
Iluvien has been approved by the governmental agencies overseeing medical products in Belgium, the Netherlands and Luxemburg, Alimera Sciences…

Meeting NewsVideo

VIDEO: Oral eplerenone successfully treats central serous chorioretinopathy

December 4, 2019
NEPTUNE, N.J. – A 58-year-old man with distorted vision was diagnosed with central serous chorioretinopathy and was successfully treated with…

J-code activations simplify billing reimbursements for practices

December 3, 2019
Several CMS-designated permanent and product-specific J-codes recently went into effect, allowing three ophthalmology-minded pharmaceutical companies…

In the JournalsPerspective

Patients with diabetes seldom need treatment 2 years after uneventful retinal screening

November 25, 2019
Patients with minimal or no retinopathy are unlikely to require retinal treatment for diabetic retinopathy within 2 years of screening, according to…

In the Journals

Use of mask after ROP exam helps minimize stress in infants

November 22, 2019
Using a mask to decrease photosensitivity following screening for retinopathy of prematurity reduced stress in the infants after the examination…

In the JournalsPerspective

HbA1c a major risk factor in retinopathy progression

November 22, 2019
The strongest risk factor in the progression of retinopathy was mean HbA1c, according to findings presented in Diabetes Care. The researchers also…

ProQR’s retinitis pigmentosa treatment gets orphan drug designation

November 21, 2019
QR-1123, a first-in-class investigational antisense oligonucleotide for the treatment of vision loss associated with autosomal dominant retinitis…

In the JournalsPerspective

OCT changes minimally related to visual acuity variation

November 21, 2019
Changes in central subfield thickness may account for only a low percentage of total variations in visual acuity changes, according to findings…

In the JournalsPerspective

Statin therapy linked to decreased risk of diabetic retinopathy

November 20, 2019
Statin therapy was shown to be associated with a decreased risk of diabetic retinopathy in patients with type 2 diabetes and dyslipidemia, according…

Meeting NewsVideo

VIDEO: AI, deep learning rapidly evolving to real-world applications in diagnosing retinal disease

November 19, 2019
NEW YORK — At OSN New York 2019, Darius Moshfeghi, MD, discusses the progress being made around the world in research into artificial…